[{"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-001", "question": "A 68-year-old man with a history of severe COPD (FEV1 35% predicted) and chronic hypercapnia (baseline PaCO2 55 mmHg) presents with acute-on-chronic hypercapnic respiratory failure requiring non-invasive ventilation. After 48 hours of improvement, his arterial blood gas shows pH 7.36, PaCO2 48 mmHg, PaO2 85 mmHg on 2 L/min nasal cannula. He is alert and comfortable. The next most appropriate step in management is:", "options": ["Gradually wean and discontinue supplemental oxygen to target a PaO2 of 55-60 mmHg", "Continue current oxygen therapy and plan for discharge home with home oxygen", "Increase oxygen flow to achieve a PaO2 > 88 mmHg", "Obtain a venous blood gas to confirm the arterial values", "Initiate acetazolamide 250 mg twice daily to accelerate renal compensation"], "answer": "A", "answer_index": 0, "explanation": "In patients with chronic hypercapnia, the hypoxic drive is a primary respiratory stimulus. Over-oxygenation can suppress this drive, leading to worsening hypercapnia and acidosis. The target PaO2 is 55-60 mmHg or SpO2 88-92%, which provides adequate oxygenation while minimizing the risk of CO2 retention. Increasing oxygen (C) is dangerous, and acetazolamide (E) is not indicated in acute-on-chronic respiratory failure as it can worsen acidosis by inhibiting compensatory metabolic alkalosis.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). The keyed answer A is not the best clinical choice. While targeting PaO2 55-60 mmHg is taught for acute COPD exacerbations to minimize CO2 retention, rigidly applying this during recovery is inappropriate. The patient is stable, alert, and comfortable on 2L NC with PaO2 85 mmHg—a safe, adequate level. Discontinuing supplemental oxygen risks recurrent hypoxemia and fails to address his severe COPD and recent respiratory failure, for which he likely qualifies for home oxygen. Option B (continue current therapy and plan discharge with home oxygen) is superior as it maintains stability while addressing long-term needs. The explanation's focus on \\\"hypoxic drive\\\" oversimplifies CO2 retention mechanisms. The question conflates acute management principles with discharge planning. Options C, D, and E are clearly incorrect. Minimal fix: Change the key to B and revise the explanation to emphasize that stable patients with severe COPD and recent hypercapnic failure should be evaluated for home oxygen therapy rather than aggressively weaned to subnormal PaO2 targets.\", \"medical_accuracy_score\": 3, \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). The keyed answer A is not the best clinical choice. While targeting PaO2 55-60 mmHg is taught for acute COPD exacerbations to minimize CO2 retention, rigidly applying this during recovery is inappropriate. The patient is stable, alert, and comfortable on 2L NC with PaO2 85 mmHg—a safe, adequate level. Discontinuing supplemental oxygen risks recurrent hypoxemia and fails to address his severe COPD and recent respiratory failure, for which he likely qualifies for home oxygen. Option B (continue current therapy and plan discharge with home oxygen) is superior as it maintains stability while addressing long-term needs. The explanation's focus on \"hypoxic drive\" oversimplifies CO2 retention mechanisms. The question conflates acute management principles with discharge planning. Options C, D, and E are clearly incorrect. Minimal fix: Change the key to B and revise the explanation to emphasize that stable patients with severe COPD and recent hypercapnic failure should be evaluated for home oxygen therapy rather than aggressively weaned to subnormal PaO2 targets.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-002", "question": "A 45-year-old woman with a history of recurrent calcium oxalate kidney stones presents with acute pancreatitis. Lipase is 1200 U/L, calcium 11.8 mg/dL, PTH 85 pg/mL (normal 10-65). She is not on lithium or thiazides. A pancreatic protocol CT shows diffuse gland enlargement but no necrosis or ductal dilation. The most likely underlying etiology of her pancreatitis is:", "options": ["Primary hyperparathyroidism due to parathyroid adenoma", "Autoimmune pancreatitis (IgG4-related disease)", "Hereditary pancreatitis due to PRSS1 mutation", "Hypertriglyceridemia-induced pancreatitis", "Pancreatitis secondary to a gastrinoma (Zollinger-Ellison syndrome)"], "answer": "A", "answer_index": 0, "explanation": "The triad of hypercalcemia, elevated PTH, and recurrent calcium oxalate stones is classic for primary hyperparathyroidism. Hypercalcemia is a known, though uncommon, cause of pancreatitis. The elevated PTH confirms primary hyperparathyroidism, not secondary causes. While hypertriglyceridemia (D) can cause pancreatitis, it doesn't explain the hypercalcemia and elevated PTH. Gastrinoma (E) is associated with ulcers and diarrhea, not typically hypercalcemia and stones.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict: The keyed answer A is the correct best answer. Key stem clues: hypercalcemia (Ca 11.8 mg/dL), elevated PTH (85 pg/mL), recurrent calcium oxalate stones, diffuse pancreatic enlargement on CT without necrosis or ductal dilation. These findings are classic for primary hyperparathyroidism, a known cause of pancreatitis. Alternative options are inconsistent: autoimmune pancreatitis (IgG4-related) would have elevated IgG4 and different imaging; hereditary pancreatitis would present earlier and without hypercalcemia; hypertriglyceridemia would require elevated triglycerides; gastrinoma would cause hypergastrinemia and peptic ulcers, not hypercalcemia. No internal contradictions; a single best answer is defensible. Medical accuracy: hypercalcemia-induced pancreatitis is a recognized entity, and the lab pattern confirms primary hyperparathyroidism. Minor nuance: hypercalcemia-induced pancreatitis is rare, but still a valid board concept. No major inaccuracies. Minimal fix: add a line stating that serum triglycerides are normal to explicitly exclude hypertriglyceridemia.\",\n\"medical_accuracy_score\": 4,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: The keyed answer A is the correct best answer. Key stem clues: hypercalcemia (Ca 11.8 mg/dL), elevated PTH (85 pg/mL), recurrent calcium oxalate stones, diffuse pancreatic enlargement on CT without necrosis or ductal dilation. These findings are classic for primary hyperparathyroidism, a known cause of pancreatitis. Alternative options are inconsistent: autoimmune pancreatitis (IgG4-related) would have elevated IgG4 and different imaging; hereditary pancreatitis would present earlier and without hypercalcemia; hypertriglyceridemia would require elevated triglycerides; gastrinoma would cause hypergastrinemia and peptic ulcers, not hypercalcemia. No internal contradictions; a single best answer is defensible. Medical accuracy: hypercalcemia-induced pancreatitis is a recognized entity, and the lab pattern confirms primary hyperparathyroidism. Minor nuance: hypercalcemia-induced pancreatitis is rare, but still a valid board concept. No major inaccuracies. Minimal fix: add a line stating that serum triglycerides are normal to explicitly exclude hypertriglyceridemia.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-003", "question": "A 32-year-old woman presents with 3 weeks of progressive dyspnea and fatigue. Echocardiogram shows a large pericardial effusion with diastolic right atrial and right ventricular collapse. Right heart catheterization reveals equalization of diastolic pressures (RA 18, RV 18, PA 18/20, PCWP 18 mmHg). After pericardiocentesis of 800 mL of serosanguinous fluid, hemodynamics improve. Cytology is negative. Two days later, she develops recurrent dyspnea. Repeat echo shows reaccumulation of the effusion. The most appropriate definitive management is:", "options": ["Repeat pericardiocentesis and initiate colchicine", "Surgical creation of a pericardial window via subxiphoid approach", "Initiation of high-dose prednisone for suspected autoimmune pericarditis", "Pericardiectomy via left thoracotomy", "Intrapericardial instillation of bleomycin"], "answer": "B", "answer_index": 1, "explanation": "Recurrent symptomatic pericardial effusion with tamponade physiology, especially when cytology is negative (ruling out malignancy requiring specific therapy), is a clear indication for a definitive surgical procedure to prevent reaccumulation. A surgical pericardial window (subxiphoid or video-assisted) allows for drainage and biopsy. Pericardiectomy (D) is reserved for constrictive pericarditis. Steroids (C) are for inflammatory causes but are not definitive for recurrent effusion. Intrapericardial chemotherapy (E) is for malignant effusions.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The vignette describes a 32-year-old woman with recurrent large pericardial effusion causing tamponade physiology—equalized diastolic pressures and echocardiographic collapse—after initial pericardiocentesis yielded serosanguinous fluid with negative cytology. Rapid reaccumulation within 2 days is the critical discriminating clue that mandates definitive surgical intervention. These features uniquely support surgical pericardial window (B) as the most appropriate definitive management. The negative cytology and young age appropriately exclude malignant effusion (E), making intrapericardial chemotherapy inappropriate. Option A fails as \\\"definitive\\\" given the rapid reaccumulation rate and does not prevent further episodes. Option C addresses inflammatory pathophysiology but provides no immediate mechanical relief or reliable recurrence prevention. Option D (pericardiectomy) is excessively invasive for effusion without constrictive physiology. No internal contradictions exist, and options permit clear discrimination. Medical accuracy score: 5. The rationale aligns perfectly with ESC pericardial disease guidelines and standard cardiothoracic practice, where pericardial window is indicated for recurrent tamponade refractory to conservative measures. The scenario is clinically realistic and board-relevant. No fix required; the item is well-constructed with appropriate option discrimination.\",\"medical_accuracy_score\":5,\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The vignette describes a 32-year-old woman with recurrent large pericardial effusion causing tamponade physiology—equalized diastolic pressures and echocardiographic collapse—after initial pericardiocentesis yielded serosanguinous fluid with negative cytology. Rapid reaccumulation within 2 days is the critical discriminating clue that mandates definitive surgical intervention. These features uniquely support surgical pericardial window (B) as the most appropriate definitive management. The negative cytology and young age appropriately exclude malignant effusion (E), making intrapericardial chemotherapy inappropriate. Option A fails as \"definitive\" given the rapid reaccumulation rate and does not prevent further episodes. Option C addresses inflammatory pathophysiology but provides no immediate mechanical relief or reliable recurrence prevention. Option D (pericardiectomy) is excessively invasive for effusion without constrictive physiology. No internal contradictions exist, and options permit clear discrimination. Medical accuracy score: 5. The rationale aligns perfectly with ESC pericardial disease guidelines and standard cardiothoracic practice, where pericardial window is indicated for recurrent tamponade refractory to conservative measures. The scenario is clinically realistic and board-relevant. No fix required; the item is well-constructed with appropriate option discrimination.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-004", "question": "A 70-year-old man with atrial fibrillation on apixaban (non-valvular) presents with acute onset of right-sided weakness and aphasia 4 hours after symptom onset. NIHSS is 15. CT head shows no hemorrhage. He is not a candidate for IV tPA due to anticoagulation. CT angiography shows a left M1 MCA occlusion. The most appropriate acute intervention is:", "options": ["Administer IV tPA after checking an INR and anti-Xa level", "Proceed directly to mechanical thrombectomy without thrombolysis", "Administer IV protamine to reverse apixaban, then give IV tPA", "Administer andexanet alfa, then give IV tPA", "Initiate IV heparin drip and observe for neurological improvement"], "answer": "B", "answer_index": 1, "explanation": "For patients with acute ischemic stroke and large vessel occlusion (LVO) who are not candidates for IV tPA, mechanical thrombectomy is the standard of care if performed within 24 hours of last known well and meeting other criteria (like NIHSS ≥6). Direct thrombectomy is non-inferior to bridging therapy (tPA + thrombectomy). Reversing anticoagulation to give tPA (C, D) delays definitive therapy and adds bleeding risk. Giving tPA on top of therapeutic anticoagulation (A) is contraindicated.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). The vignette clearly describes an acute LVO stroke (M1 occlusion, NIHSS 15) in a patient on therapeutic apixaban, making IV tPA contraindicated. Key clues—4-hour onset, no hemorrhage, high NIHSS—unambiguously support mechanical thrombectomy as standard of care. The keyed answer B is correct and defensible: direct thrombectomy is guideline-endorsed and non-inferior to bridging therapy. Distractors are appropriately inferior: A proposes tPA despite contraindication with inappropriate labs; C contains a factual error (protamine does not reverse apixaban); D advocates off-label reversal causing dangerous delay; E offers ineffective medical management. No internal contradictions exist. Medical accuracy is strong but imperfect due to the protamine error in distractor C. The explanation correctly identifies reversal strategy flaws. Minimal fix: replace 'protamine' in option C with 'vitamin K' (still ineffective for apixaban but factually accurate) or substitute the entire option with 'Observe on aspirin alone'.\",\n\"medical_accuracy_score\": 4,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The vignette clearly describes an acute LVO stroke (M1 occlusion, NIHSS 15) in a patient on therapeutic apixaban, making IV tPA contraindicated. Key clues—4-hour onset, no hemorrhage, high NIHSS—unambiguously support mechanical thrombectomy as standard of care. The keyed answer B is correct and defensible: direct thrombectomy is guideline-endorsed and non-inferior to bridging therapy. Distractors are appropriately inferior: A proposes tPA despite contraindication with inappropriate labs; C contains a factual error (protamine does not reverse apixaban); D advocates off-label reversal causing dangerous delay; E offers ineffective medical management. No internal contradictions exist. Medical accuracy is strong but imperfect due to the protamine error in distractor C. The explanation correctly identifies reversal strategy flaws. Minimal fix: replace 'protamine' in option C with 'vitamin K' (still ineffective for apixaban but factually accurate) or substitute the entire option with 'Observe on aspirin alone'.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-005", "question": "A 55-year-old man with alcoholic cirrhosis (Child-Pugh B) is admitted with hepatic encephalopathy. He is started on lactulose. On day 3, he develops acute kidney injury. Serum sodium is 122 mEq/L (down from 128 on admission), creatinine 2.4 mg/dL (baseline 0.9), and he is clinically envolemic. Urine sodium is <10 mEq/L, urine osmolality 550 mOsm/kg. The most likely cause of his hyponatremia is:", "options": ["Syndrome of inappropriate antidiuretic hormone secretion (SIADH)", "Acute tubular necrosis from sepsis", "Hepatorenal syndrome type 1", "Pseudohyponatremia from hypertriglyceridemia", "Hyponatremia due to lactulose-induced diarrhea"], "answer": "E", "answer_index": 4, "explanation": "Lactulose causes an osmotic diarrhea, leading to loss of sodium and water, but relatively more water loss, resulting in hypertonic hyponatremia. The clinical picture (envolemic, high urine osmolality, low urine sodium) is consistent with volume depletion from GI losses, not SIADH (which has inappropriately high urine sodium). Hepatorenal syndrome (C) is characterized by low urine sodium but typically occurs in the setting of avid sodium retention and ascites, not acute diarrhea. ATN (B) would have high urine sodium.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"A 55-year-old man with alcoholic cirrhosis and hepatic encephalopathy on lactulose develops AKI and hyponatremia (Na 122, Cr 2.4). He is clinically euvolemic, urine Na <10, urine osmolality 550. The question asks the most likely cause of hyponatremia. Key findings: euvolemic exam, low urine Na, high urine osmolality, recent lactulose. These suggest either GI loss from diarrhea or hepatorenal syndrome type 1 (HRS‑1). The keyed answer (E) blames lactulose‑induced diarrhea. While lactulose can cause osmotic diarrhea and low urine Na, calling the patient euvolemic contradicts clinically significant volume loss. Moreover, the explanation erroneously coins 'hypertonic hyponatremia,' a major factual error. Alternatives: SIADH (A) and ATN (B) are unlikely given low urine Na and high osmolality; pseudohyponatremia (D) is unsupported. HRS‑1 (C) fits the labs and cirrhotic setting, but the vignette omits ascites, a required criterion, making the item underspecified. Thus the item has internal inconsistency (euvolemic vs. volume loss) and is underspecified for HRS‑1, allowing two defensible answers. The keyed answer is not uniquely best and contains a major error. Validity label: C (contradiction) with secondary U (underspecified). Verdict: miskeyed/ambiguous. Minimal fix: either state the patient has diarrhea with signs of hypovolemia, or add ascites and clarify HRS‑1 as the target, and correct the explanation.\",\n\"medical_accuracy_score\": 2,\n\"logical_validity\": false,\n\"logical_false_reason\": \"C\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "A 55-year-old man with alcoholic cirrhosis and hepatic encephalopathy on lactulose develops AKI and hyponatremia (Na 122, Cr 2.4). He is clinically euvolemic, urine Na <10, urine osmolality 550. The question asks the most likely cause of hyponatremia. Key findings: euvolemic exam, low urine Na, high urine osmolality, recent lactulose. These suggest either GI loss from diarrhea or hepatorenal syndrome type 1 (HRS‑1). The keyed answer (E) blames lactulose‑induced diarrhea. While lactulose can cause osmotic diarrhea and low urine Na, calling the patient euvolemic contradicts clinically significant volume loss. Moreover, the explanation erroneously coins 'hypertonic hyponatremia,' a major factual error. Alternatives: SIADH (A) and ATN (B) are unlikely given low urine Na and high osmolality; pseudohyponatremia (D) is unsupported. HRS‑1 (C) fits the labs and cirrhotic setting, but the vignette omits ascites, a required criterion, making the item underspecified. Thus the item has internal inconsistency (euvolemic vs. volume loss) and is underspecified for HRS‑1, allowing two defensible answers. The keyed answer is not uniquely best and contains a major error. Validity label: C (contradiction) with secondary U (underspecified). Verdict: miskeyed/ambiguous. Minimal fix: either state the patient has diarrhea with signs of hypovolemia, or add ascites and clarify HRS‑1 as the target, and correct the explanation.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-006", "question": "A 28-year-old pregnant woman at 32 weeks gestation is admitted for severe preeclampsia with BP 170/110 mmHg. She is started on IV magnesium sulfate for seizure prophylaxis and IV labetalol for blood pressure control. One hour after initiation of magnesium, she becomes somnolent, with loss of deep tendon reflexes. Respiratory rate is 8 breaths/min. Serum magnesium level is 9.2 mg/dL. After securing the airway, the most specific immediate treatment is:", "options": ["IV administration of 10% calcium gluconate 1 gram over 10 minutes", "IV administration of furosemide 40 mg to enhance renal excretion", "Immediate hemodialysis", "Discontinuation of magnesium sulfate and administration of IV levothyroxine", "IV administration of pyridostigmine 2 mg"], "answer": "A", "answer_index": 0, "explanation": "Calcium gluconate is the direct antagonist to the life-threatening cardiac and neuromuscular effects of hypermagnesemia. It stabilizes cardiac membranes and reverses respiratory depression caused by magnesium. Furosemide (B) promotes excretion but is not immediate. Dialysis (C) is for severe cases with renal failure but is not the first step after airway management. Pyridostigmine (E) is for myasthenia, not magnesium toxicity.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). The vignette clearly establishes magnesium toxicity secondary to preeclampsia prophylaxis: somnolence, loss of deep tendon reflexes, respiratory rate 8/min, and serum magnesium 9.2 mg/dL are classic findings. After airway securing, the most specific immediate treatment is IV calcium gluconate, which directly antagonizes magnesium's cardiac and neuromuscular toxicity. The keyed answer A is correct and uniquely defensible. Distractors are properly excluded: furosemide (B) promotes renal excretion but lacks immediate effect and may be limited by preeclampsia-related renal hypoperfusion; hemodialysis (C) is indicated only for severe renal failure or refractory cases, not as first-line; levothyroxine (D) is therapeutically irrelevant; pyridostigmine (E) treats myasthenia gravis and would not reverse magnesium blockade. No internal inconsistencies or option overlap compromise the item. Medical accuracy is gold-standard: calcium gluconate is the evidence-based antidote per obstetric guidelines, the 1 g dose over 10 minutes is standard, and the scenario is clinically authentic. No revision needed.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). The vignette clearly establishes magnesium toxicity secondary to preeclampsia prophylaxis: somnolence, loss of deep tendon reflexes, respiratory rate 8/min, and serum magnesium 9.2 mg/dL are classic findings. After airway securing, the most specific immediate treatment is IV calcium gluconate, which directly antagonizes magnesium's cardiac and neuromuscular toxicity. The keyed answer A is correct and uniquely defensible. Distractors are properly excluded: furosemide (B) promotes renal excretion but lacks immediate effect and may be limited by preeclampsia-related renal hypoperfusion; hemodialysis (C) is indicated only for severe renal failure or refractory cases, not as first-line; levothyroxine (D) is therapeutically irrelevant; pyridostigmine (E) treats myasthenia gravis and would not reverse magnesium blockade. No internal inconsistencies or option overlap compromise the item. Medical accuracy is gold-standard: calcium gluconate is the evidence-based antidote per obstetric guidelines, the 1 g dose over 10 minutes is standard, and the scenario is clinically authentic. No revision needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-007", "question": "A 62-year-old man with a history of asbestos exposure 30 years ago presents with unilateral right-sided pleural effusion. Thoracentesis reveals exudative fluid (by Light's criteria) with cytology positive for adenocarcinoma. PET-CT shows FDG-avid right pleural thickening and effusion, with no other distant metastases. The next best step in management is:", "options": ["Systemic chemotherapy with platinum-pemetrexed", "Pleurodesis followed by systemic chemotherapy", "Extrapleural pneumonectomy", "Pleurectomy/decortication followed by adjuvant chemoradiation", "Immunotherapy with pembrolizumab as first-line treatment"], "answer": "D", "answer_index": 3, "explanation": "This describes a likely diagnosis of malignant pleural mesothelioma (given asbestos exposure, unilateral effusion, pleural thickening). For resectable disease (stage I-III) in a fit patient, the standard of care is maximal cytoreductive surgery (pleurectomy/decortication) followed by adjuvant chemotherapy and possibly radiation. Extrapleural pneumonectomy (C) is a more radical, less commonly performed option. Systemic therapy alone (A) is for unresectable disease. Pleurodesis (B) is palliative.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: C (Contradiction). The stem reports cytology 'positive for adenocarcinoma,' but the answer explanation presumes malignant pleural mesothelioma. This represents a critical pathologic contradiction—mesothelioma and adenocarcinoma are distinct entities with divergent natural histories and management pathways. If the stem is taken literally, surgical options C and D are contraindicated for metastatic adenocarcinoma, rendering the keyed answer D medically indefensible and potentially dangerous. If mesothelioma was the intended diagnosis, the stem contains a fatal terminology error that invalidates the entire question. While key clinical clues (remote asbestos exposure, unilateral pleural thickening, absence of distant metastases) are compatible with mesothelioma, the explicit cytologic diagnosis of adenocarcinoma cannot be disregarded. This internal inconsistency makes the item logically unsolvable without assuming an unstated typographical error. Medical accuracy is severely compromised by conflating two unrelated malignancies. Minimal fix: Replace 'adenocarcinoma' with 'malignant mesothelioma' and add 'in a surgely fit patient' to explicitly justify maximal cytoreduction as the unambiguous next step.\",\n\"medical_accuracy_score\": 2,\n\"logical_validity\": false,\n\"logical_false_reason\": \"C\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: C (Contradiction). The stem reports cytology 'positive for adenocarcinoma,' but the answer explanation presumes malignant pleural mesothelioma. This represents a critical pathologic contradiction—mesothelioma and adenocarcinoma are distinct entities with divergent natural histories and management pathways. If the stem is taken literally, surgical options C and D are contraindicated for metastatic adenocarcinoma, rendering the keyed answer D medically indefensible and potentially dangerous. If mesothelioma was the intended diagnosis, the stem contains a fatal terminology error that invalidates the entire question. While key clinical clues (remote asbestos exposure, unilateral pleural thickening, absence of distant metastases) are compatible with mesothelioma, the explicit cytologic diagnosis of adenocarcinoma cannot be disregarded. This internal inconsistency makes the item logically unsolvable without assuming an unstated typographical error. Medical accuracy is severely compromised by conflating two unrelated malignancies. Minimal fix: Replace 'adenocarcinoma' with 'malignant mesothelioma' and add 'in a surgely fit patient' to explicitly justify maximal cytoreduction as the unambiguous next step.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-008", "question": "A 40-year-old woman presents with palpitations, heat intolerance, and weight loss. TSH is <0.01 mIU/L, free T4 is 3.2 ng/dL (high). Thyroid ultrasound shows a 2 cm hypoechoic nodule in the right lobe. Radioactive iodine uptake scan shows diffusely increased uptake (45% at 24 hours) with a photopenic area corresponding to the nodule. The most likely diagnosis is:", "options": ["Graves' disease with a coexisting cold nodule", "Toxic multinodular goiter", "Subacute thyroiditis", "Factitious thyrotoxicosis", "Marine-Lenhart syndrome (Graves' disease with a functioning nodule)"], "answer": "A", "answer_index": 0, "explanation": "The diffusely increased uptake is diagnostic of Graves' disease. The photopenic ('cold') nodule within an area of diffusely high uptake indicates a non-functioning nodule, which raises concern for malignancy and requires FNA biopsy. Marine-Lenhart syndrome (E) is Graves' with a *functioning* (hot) nodule. Toxic MNG (B) would show multiple areas of increased uptake. Subacute thyroiditis (C) shows very low uptake.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (valid). The stem provides classic Graves’ disease features: markedly suppressed TSH, elevated free T4, and a diffusely high radioactive iodine uptake (45 % at 24 h). The photopenic area that matches a 2 cm hypoechoic nodule indicates a nonfunctioning (cold) nodule within an otherwise hyperfunctioning gland—this pattern is pathognomonic for Graves’ disease with a coexisting cold nodule (Answer A). The keyed answer is correct and uniquely defensible. All other options are clearly excluded: toxic multinodular goiter would show multiple discrete hot foci rather than diffuse uptake; subacute thyroiditis and factitious thyrotoxicosis both present with very low RAIU; and Marine‑Lenhart syndrome requires a hyperfunctioning (hot) nodule, which is absent here. No internal contradictions or missing critical details are present. Medical accuracy is high: the explanation correctly states that a cold nodule in Graves’ disease raises suspicion for malignancy and warrants ultrasound‑guided FNA biopsy, aligning with current ATA guidelines. No logical or factual flaws are identified. Minimal fix: none required; the item is already unambiguous, clinically accurate, and board‑appropriate.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (valid). The stem provides classic Graves’ disease features: markedly suppressed TSH, elevated free T4, and a diffusely high radioactive iodine uptake (45 % at 24 h). The photopenic area that matches a 2 cm hypoechoic nodule indicates a nonfunctioning (cold) nodule within an otherwise hyperfunctioning gland—this pattern is pathognomonic for Graves’ disease with a coexisting cold nodule (Answer A). The keyed answer is correct and uniquely defensible. All other options are clearly excluded: toxic multinodular goiter would show multiple discrete hot foci rather than diffuse uptake; subacute thyroiditis and factitious thyrotoxicosis both present with very low RAIU; and Marine‑Lenhart syndrome requires a hyperfunctioning (hot) nodule, which is absent here. No internal contradictions or missing critical details are present. Medical accuracy is high: the explanation correctly states that a cold nodule in Graves’ disease raises suspicion for malignancy and warrants ultrasound‑guided FNA biopsy, aligning with current ATA guidelines. No logical or factual flaws are identified. Minimal fix: none required; the item is already unambiguous, clinically accurate, and board‑appropriate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-009", "question": "A 50-year-old man with diabetes mellitus and hypertension is found to have a serum potassium of 6.8 mEq/L on routine labs. He is asymptomatic. ECG shows peaked T waves. He is given IV calcium gluconate, insulin/dextrose, and albuterol. His potassium decreases to 6.0 mEq/L. Renal function is normal. Further workup reveals a low serum aldosterone and elevated plasma renin activity. The most likely cause of his hyperkalemia is:", "options": ["Type 4 renal tubular acidosis (hyporeninemic hypoaldosteronism)", "Addison's disease", "Gordon's syndrome (pseudohypoaldosteronism type II)", "Spironolactone use", "Rhabdomyolysis"], "answer": "C", "answer_index": 2, "explanation": "Gordon's syndrome (familial hyperkalemic hypertension) is characterized by hyperkalemia, hypertension, normal GFR, metabolic acidosis, and *suppressed* renin but *normal or high* aldosterone. The key here is the elevated renin, which rules out hyporeninemic hypoaldosteronism (A, which has low renin and low aldosterone) and points to a primary renal defect in potassium excretion. Addison's (B) has low aldosterone and high renin but also has hyponatremia and hypotension.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: K (Miskeyed). The vignette provides low serum aldosterone and elevated plasma renin activity, a pattern classic for primary adrenal insufficiency (Addison’s disease). The patient’s hypertension does not exclude Addison’s; essential hypertension often coexists. Option B (Addison’s disease) matches the labs, whereas option C (Gordon’s syndrome) is characterized by suppressed renin and normal or high aldosterone, opposite to the findings. The answer key incorrectly selects C, and the explanation erroneously claims that elevated renin points to a primary renal defect and misstates Gordon’s syndrome features. This miskey invalidates the item. The stem is otherwise sufficient and internally consistent; no other option fits the lab pattern. The primary logical flaw is a miskeyed answer; the item is not underspecified nor contradictory. Medical accuracy is compromised because the keyed answer and explanation contradict established physiology and mislabel Gordon’s syndrome. Minimal fix: Change the key to B and rewrite the rationale to reflect that low aldosterone with high renin indicates Addison’s disease, noting that hypertension can be incidental.\",\n\"medical_accuracy_score\": 2,\n\"logical_validity\": false,\n\"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). The vignette provides low serum aldosterone and elevated plasma renin activity, a pattern classic for primary adrenal insufficiency (Addison’s disease). The patient’s hypertension does not exclude Addison’s; essential hypertension often coexists. Option B (Addison’s disease) matches the labs, whereas option C (Gordon’s syndrome) is characterized by suppressed renin and normal or high aldosterone, opposite to the findings. The answer key incorrectly selects C, and the explanation erroneously claims that elevated renin points to a primary renal defect and misstates Gordon’s syndrome features. This miskey invalidates the item. The stem is otherwise sufficient and internally consistent; no other option fits the lab pattern. The primary logical flaw is a miskeyed answer; the item is not underspecified nor contradictory. Medical accuracy is compromised because the keyed answer and explanation contradict established physiology and mislabel Gordon’s syndrome. Minimal fix: Change the key to B and rewrite the rationale to reflect that low aldosterone with high renin indicates Addison’s disease, noting that hypertension can be incidental.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-010", "question": "A 65-year-old man with a mechanical aortic valve (On-X) on warfarin presents with a transient ischemic attack. INR on presentation is 1.8 (target 2.5-3.5). He has no bleeding history. The most appropriate adjustment to his antithrombotic regimen is:", "options": ["Increase warfarin dose to achieve INR 2.5-3.5; add aspirin 81 mg daily", "Increase warfarin dose to achieve INR 2.5-3.5; no aspirin needed", "Switch to apixaban 5 mg twice daily", "Add clopidogrel 75 mg daily to current warfarin therapy", "Discontinue warfarin and initiate dual antiplatelet therapy with aspirin and clopidogrel"], "answer": "A", "answer_index": 0, "explanation": "For a mechanical aortic valve, the standard of care is warfarin with a target INR of 2.5-3.5. In patients who have a thromboembolic event despite therapeutic INR, adding aspirin 75-100 mg is recommended. Since his INR was subtherapeutic at the time of the TIA, the first step is to optimize INR control. However, given the event, adding low-dose aspirin is now indicated based on PROACT and other trials. Direct oral anticoagulants (C) are contraindicated in mechanical valves. Dual antiplatelet therapy (E) is inferior to warfarin for valve protection.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible). The vignette describes a mechanical aortic valve patient with TIA while subtherapeutic (INR 1.8). While increasing warfarin dose is unequivocally indicated, whether to simultaneously add aspirin 81 mg (Option A) versus optimize anticoagulation alone (Option B) is not definitively resolved by the stem. Key stem clues: mechanical On-X valve, subtherapeutic INR at time of event, no bleeding history. The explanation incorrectly invokes PROACT trial (which studied aspirin in ischemic stroke, not mechanical valves) to justify adding aspirin after any thromboembolic event. Current ACC/AHA guidelines recommend adding aspirin only for systemic embolism despite therapeutic INR, not when subtherapeutic. Therefore, Option B (optimize INR alone) is equally defensible as best initial adjustment, creating two viable pathways. Main logical issue: The stem fails to specify whether the TIA occurred despite adequate prior anticoagulation or specifically due to documented subtherapeutic INR, making aspirin addition ambiguous. Main medical accuracy issue: Misrepresentation of evidence base for aspirin in mechanical valve patients with subtherapeutic INR at event time. Minimal fix: Revise stem to state patient had TIA while INR was documented therapeutic (e.g., INR 2.8 one week prior) or change key to B and revise explanation to reflect guideline-concordant stepwise approach.\",\"medical_accuracy_score\":3,\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). The vignette describes a mechanical aortic valve patient with TIA while subtherapeutic (INR 1.8). While increasing warfarin dose is unequivocally indicated, whether to simultaneously add aspirin 81 mg (Option A) versus optimize anticoagulation alone (Option B) is not definitively resolved by the stem. Key stem clues: mechanical On-X valve, subtherapeutic INR at time of event, no bleeding history. The explanation incorrectly invokes PROACT trial (which studied aspirin in ischemic stroke, not mechanical valves) to justify adding aspirin after any thromboembolic event. Current ACC/AHA guidelines recommend adding aspirin only for systemic embolism despite therapeutic INR, not when subtherapeutic. Therefore, Option B (optimize INR alone) is equally defensible as best initial adjustment, creating two viable pathways. Main logical issue: The stem fails to specify whether the TIA occurred despite adequate prior anticoagulation or specifically due to documented subtherapeutic INR, making aspirin addition ambiguous. Main medical accuracy issue: Misrepresentation of evidence base for aspirin in mechanical valve patients with subtherapeutic INR at event time. Minimal fix: Revise stem to state patient had TIA while INR was documented therapeutic (e.g., INR 2.8 one week prior) or change key to B and revise explanation to reflect guideline-concordant stepwise approach.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}]